UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045799
Receipt number R000052287
Scientific Title Survey of clinical practice and prognostic factors for unresectable locally advanced pancreatic cancer: Multicenter prospective observational study
Date of disclosure of the study information 2021/10/20
Last modified on 2022/11/10 01:38:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey of clinical practice and prognostic factors for unresectable locally advanced pancreatic cancer: Multicenter prospective observational study

Acronym

HOPS-UR02

Scientific Title

Survey of clinical practice and prognostic factors for unresectable locally advanced pancreatic cancer: Multicenter prospective observational study

Scientific Title:Acronym

HOPS-UR02

Region

Japan


Condition

Condition

pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Survey of clinical practice and prognostic factor for locally advanced unresectable pancreatic cancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

overall survival

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Unresectable locally advanced pancreatic cancer has been diagnosed by chest CT and abdominal contrast CT.
2. Invasive pancreatic ductal carcinoma (adenocarcinoma, adenosquamous carcinoma, mucinous carcinoma, anaplastic carcinoma) has been diagnosed by histological or cytological examination.
3. Distant metastasis corresponding to M1 is not found on the image.
d. First-line treatment (no history of treatment for pancreatic cancer).
e. The age of registration date is 20 years or older.
f. Written consent of the individual or his / her representative has been obtained for participation in the study.

Key exclusion criteria

1. Your physician determines that you are unsuitable for enrollment in the study.
2. Contrast-enhanced CT imaging is not possible due to drug allergy to iodine-based contrast media. However, contrast-enhanced CT imaging is not possible with steroid prophylactic administration.
3. Pleural effusion and ascites for which metastasis cannot be ruled out are observed on chest CT and abdominal / pelvic contrast CT.
4. Contrast-enhanced MRI shows a liver mass that metastasis cannot be ruled out.
5. Active double cancer (simultaneous double cancer). However, lesions such as carcinoma in situ or intramucosal cancer that are judged to be cured by topical therapy are not included in active double cancer.

Target sample size

130


Research contact person

Name of lead principal investigator

1st name Masaki
Middle name
Last name Kuwatani

Organization

Hokkaido University Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code

060-8648

Address

West 5, North 14, Kita-ku, Sapporo

TEL

011-716-1161

Email

mkuwatan@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Yoshida

Organization

Sapporo Medical University Hospital

Division name

Department of clinical Oncology

Zip code

060-8543

Address

West 16, South 1, Chuo-Ku, Sapporo

TEL

011-611-2111

Homepage URL


Email

yoshimako10@sapmed.ac.jp


Sponsor or person

Institute

Hokkaido University Hospital

Institute

Department

Personal name



Funding Source

Organization

Hokkaido University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University Certified Review Board

Address

West 5, North 14, Kita-ku, Sapporo, Hokkaido

Tel

011-706-7934

Email

recjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 10 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 10 Month 01 Day

Date of IRB

2021 Year 10 Month 28 Day

Anticipated trial start date

2021 Year 12 Month 01 Day

Last follow-up date

2029 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Each research director and research coordinator use the EDC (Electronic Data Capture) system "NorthNet" for researchers handled by the Clinical Research and Development Center of Hokkaido University Hospital using the Internet line. Accumulate. Collected data will be analyzed at the data management facility shown in the research implementationsystem.


Management information

Registered date

2021 Year 10 Month 20 Day

Last modified on

2022 Year 11 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052287